These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 11872871)

  • 1. [Decrease of HIV-1 virus load by nevirapin/efavirenz].
    Dtsch Med Wochenschr; 2003 May; 128(19):1075. PubMed ID: 12774797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].
    Hartmann M; Brust J; Schuster D; Mosthaf F; Procaccianti M; Rump JA; Klinker H; Petzoldt D
    Hautarzt; 2005 Sep; 56(9):847-53. PubMed ID: 15726299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
    Keiser P; Nassar N; Yazdani B; Armas L; Moreno S
    HIV Clin Trials; 2003; 4(5):358-60. PubMed ID: 14583852
    [No Abstract]   [Full Text] [Related]  

  • 4. Can early failure with nevirapine be rescued with efavirenz?
    Briones C; Soriano V; Dona C; Barreiro P; González-Lahoz J
    J Acquir Immune Defic Syndr; 2000 May; 24(1):76-8. PubMed ID: 10877499
    [No Abstract]   [Full Text] [Related]  

  • 5. The tolerability of efavirenz after nevirapine-related adverse events.
    Clarke S; Harrington P; Barry M; Mulcahy F
    Clin Infect Dis; 2000 Sep; 31(3):806-7. PubMed ID: 11017835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine + efavirenz based salvage therapy in heavily pretreated HIV infected patients.
    Olivieri J
    Sex Transm Infect; 2002 Feb; 78(1):72-3. PubMed ID: 11872871
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NNRTI hepatotoxicity: efavirenz versus nevirapine.
    Pulido F; Torralba M
    J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of NNRTIs in antiretroviral combination therapy: an introduction.
    Nelson M
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():1-2. PubMed ID: 11589821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of NNRTIs in antiretroviral-experienced patients.
    Maggiolo F
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():10-7. PubMed ID: 11589823
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting adherence and convenience in antiretroviral therapy.
    Lafeuillade A
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824
    [No Abstract]   [Full Text] [Related]  

  • 12. Other issues: penetration into sanctuary sites, immune reconstitution and NNRTI sequencing.
    Stellbrink HJ
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():25-32. PubMed ID: 11589825
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.